JPMorgan Chase & Co. is one of the largest financial service firms in the world. JPMorgan organizes its business through five reportable segments: Consumer & Community Banking segment serves consumers and businesses through personal service at bank branches and through automated teller machine, online, mobile and telephone banking. Corporate & Investment Bank offers a wide range of IB, market-making, prime brokerage, and wholesale payments services to global client base of corporations, investors, financial institutions, government and municipal entities. Commercial Banking segment provides lending, wholesale payments and investment banking services to corporations, municipalities, financial institutions and non-profit entities. Asset & Wealth Management segment provides services to institutions, retail investors and high-net-worth individuals. Corporate segment consists of Treasury & Chief Investment Office and Other Corporates....
+See More2018-06-02 09:35:00 Saturday ET

The finance ministers of Britain, Canada, France, Germany, Italy, and Japan team up against U.S. President Donald Trump and Treasury Secretary Steven Mnuchi
2018-10-23 12:36:00 Tuesday ET

Former Fed Chair Paul Volcker releases his memoir, talks about American public governance, and worries about plutocracy in America. Volcker suggests that pu
2017-10-21 08:45:00 Saturday ET

Netflix stares at higher content costs as Disney and Fox hold merger talks. Disney has held talks to acquire most of 21st Century Fox's business equity.
2019-07-17 12:37:00 Wednesday ET

Gold prices surge above $1400 per ounce amid global trade tension and economic policy uncertainty. Both European Central Bank and Bank of Japan may consider
2019-10-21 10:35:00 Monday ET

American state attorneys general begin bipartisan antitrust investigations into the market power and corporate behavior of central tech titans such as Apple
2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its